In this webinar, we discussed the clinical relevance of HR alterations, with a focus on the clinical, diagnostic and familiar impact of BRCA1/2 alterations.
The webinar was presented by Dr Pasquale Rescigno, Senior Clinical Lecturer at Newcastle University and Senior Researcher at Candiolo Cancer Institute, Turin.
![Cancer Immunotherapy Month | Pancreatic Cancer Demystified: Expert Insights and Breakthroughs [Video]](https://cancerrecoverygiving.com/wp-content/uploads/2024/07/mp_353172_0_0jpg.jpg)
![Miami Cancer Institute 2024 ASCO Recap [Video]](https://cancerrecoverygiving.com/wp-content/uploads/2024/07/mp_353060_0_0jpg.jpg)
![Irish star jockey Rachael Blackmore to play key role in upcoming charity GAA match Hurling For Cancer Research [Video]](https://cancerrecoverygiving.com/wp-content/uploads/2024/07/mp_350515_0_crop13303318jpg.jpg)
![Artificial Intelligence | Cancer Research | Breast Cancer | Lung Cancer | Diagnosis | Cambridge [Video]](https://cancerrecoverygiving.com/wp-content/uploads/2024/06/mp_349401_0_0jpg.jpg)
